Background
In recent years, heat shock proteins (HSP) have been implicated to be an additional factor utilized for the gastric defence mechanisms at the intracellular level [
1]. HSP70 is generally considered to be a major molecular chaperone to accelerate the cellular recovery from different stimuli by cope with unfolded or denatured proteins [
2], through which HSP70 might achieve efficient mucosal defence for ulcer or inflammation healing [
3,
4].
Helicobacter pylori (
H. pylori) infection leads to significant inflammations in the gastric mucosa, which is closely associated with development of atrophic gastritis, peptic ulcer, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma. Animal studies have demonstrated that
H. pylori infection damages gastric mucosa by either disrupting the balance in cell apoptosis and proliferation, or decreasing migration of epithelial cells within the gastric mucosa [
1,
5,
6]. Recent studies have found that
H. pylori decreases the synthesis of HSP70 in gastric epithelial cells by the inactivation of heat shock factor- 1 [
7‐
11], however, whether the inhibition of HSP70 would be the prominent event leading to the persistent damages from
H. pylori in gastric epithelial cells remains unclear.
H. pylori produces ammonia in gastric mucosa with its high urease activity. Our previous animal studies have introduced ammonia solution to simulate the conditions of
H. pylori infection, and succeeded in inducing atrophic gastritis in rats [
12]. Further studies demonstrated that induction of HSP70 expression is beneficial for preventing gastric atrophy and maintaining mucosal functions in gastric cells [
12]. Since the induction of HSP70 is suggested to constitute a novel therapeutic approach for the prevention or treatment of
H. pylori-associated conditions, it's conceivable that deregulation of HSP70 might be a prominent cause of
H. pylori-associated damages. Therefore, we investigated the correlation of HSP70 inhibition with the mucosal damages induced by
H. pylori in this study.
Methods
Cell culture and transfection
Human gastric epithelial cell line AGS (CRL-1739, ATCC, USA) were maintained in RPMI1640 medium supplemented with 10% fetal bovine serum (FBS) without antibiotics at 37°C in a humidified atmosphere of 5% CO2 and 95% air.
Small interfering RNAs (siRNAs) were designed against the mRNA sequences targeting HSP70 (Genebank: NM_005345.5), siRNA
1: 5'-CTTTCCAGGTGATCAACGA-3', siRNA
2: 5'-AGGACGAGTTTGAGCACAA-3'[
13], siRNA
3: 5'-GACTTTGCATTTCCTAGTA-3'. We used RNAi-Ready vector, which contains a neomycin resistance gene and GFP for selection of stable transfectants. In the preliminary experiments, we employed three constructs that target three distinct regions of the HSP70 gene to deplete HSP70 expression, and found siRNA
2 was better than the others for the short-term inhibition of HSP70. Therefore, siRNA
2 was selected for the following stable transfection. AGS cells were transfected with the HSP70 siRNA constructs by use of lipofectamine according to the manufacturer's protocol. The total amount of plasmids was adjusted by using the empty vector plasmid in each assay. Briefly, 1 ×10
5 cells were plated in RPMI1640 containing 10% FBS in 6-well plates 24 h before transfection. Then transfection was performed with serum-free RPMI1640 containing 2 μg plasmid constructs and 6 μl lipofectamine. After 5 h, fresh RPMI1640 containing 10% FBS was added until 2 ml of final volume. The selection with 0.4 mg/ml neomycin was started 48 h after transfection. GFP was used as a control for transfection or selection efficiency. A control sample transfected with empty vector plasmid was included. Neomycin-resistant cell pools and single cell clone were generated, in which HSP70 expression was confirmed by immunoblot analysis and real-time PCR.
Bacterial strain and coculture conditions
H. pylori expressing CagA and VacA (ATCC 700392) were grown on Columbia agar medium with 5% of fresh sheep blood under microaerobic conditions (5%O2, 10%CO2, 8%N2) at 37°C. Before the experiment, bacteria were harvested and suspended in RPMI 1640 medium (including 10% FBS but no antimicrobial agents). The bacteria were densitometrically counted according to the McFarland scale and suitable dilution was prepared for the cell culture (bacteria/cell ratio at 200:1 for most tests).
Real-time PCR
The RNA was harvested from cell culture with RNeasy columns (QIAGEN). Single stranded cDNA synthesis was made with the TaqMan RT Kit (QIAGEN) using oligo-(dT)16 primers. The cDNA originating from the transfected cells were used as template for the following PCR reaction and the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was served as an internal control. Primers were designed as follows (Genebank: NM_005345.5): HSP70-for, 5'-AACACCGTGTTTGACGCGAA-3'; HSP70-rev, 5'-GGTCAGCACCATGGACGAGA-3'; HSP70-probe, 5'-FAM-CCAGGTGATCAACGACGGAGACAAGCCC-TAMRA-3'. The negative control contained the reaction mixture but no DNA. The reactions were performed with a real-time PCR machine (BIOER, Japan) with a Taq activation at 95°C for 5 min followed by 35 cycles of three segments consisting of 30 sec at 95°C, 30 sec at 55°C, and 30 sec at 72°C. The level of HSP70 mRNA was evaluated relative to that of GAPDH mRNA.
Growth curve and cell proliferation Assay
Cell growth curve or proliferation assessment was quantified using a tetrazolium salt colorimetric assay with 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT, final concentration of 0.5 mg/ml, Sigma-Aldrich, St. Louis, MO, USA). Briefly, the cells stably transfected with HSP70 siRNA or the empty vector were cultured in a 96-well plate for 1~6 days. In the proliferation assay, these cells were incubated with live H. pylori for 0, 24, 48 or 72 hours. The absorbance of samples was measured at 492 nm in the microplate reader.
Cell apoptosis assays
Cells suspension (2 × 104) was added to each well of 48-well plates and was incubated with H. pylori (1:200) for 24 h. We analyzed apoptosis with the use of the terminal deoyecelotibyl transferase mediated dUTP-biotin nick end labeling assay (TUNEL) kit (Cell Death Detection kit, Roche, Germany) according to the instructions provided by the manufacturer. Quantitation of apoptotic cells was accomplished by counting the number of apoptotic bodies sighted in the microscopic fields. Labeling indices were calculated as the mean number of labeled cells (from five random fields of vision) divided by total counted cells (500 cells).
Cell cycle analysis
Cells were seeded (2 × 105) on 6-well plates and were synchronized through serum starvation for 48 hours. Then the cells were incubated with H. pylori at 200:1 of bacterium to cell ratio in RPMI1640 containing 10% FBS for 0, 6, 12 or 24 hours. The treated cells were collected and fixed in 70% ethanol. Cell pellets were resuspended in 500 μl of propidium iodide buffer (10 mM Tris-Cl at PH 7.5, 50 μg/ml propidium iodide, 0.1% Triton X-100, 0.1% sodium citrate and 2 mg/ml RNase) and incubated in the dark at 4°C overnight. Stained cells were analyzed by the Beckman Coulter EPICS XL flow cytometer using the CellQuest software. At least 1 × 104 cells have been tested in each test.
Immunoblotting analyses
Total proteins were isolated from the transfected cells and the concentration was measured by Bio-Rad Protein Assay. Mitochondrial or cytosolic protein was extracted in according to the protocol of Mitochondria/cytosol Fractionation Kit (BioVision). All procedures were performed at 4°C. The expressions of HSP70 (anti-HSP70, Sigma-Aldrich, St. Louis, MO, USA), Bax, caspase-3, caspase-6, caspase-7, cytochrome c, p21, PCNA (antibodies, Cell Signaling Technology, Danvers, MA, USA) and AIF (anti-AIF, Santa Cruz Biotechnology, Santa Cruz, CA) were assessed by immunoblotting with corresponding antibodies. The blotted membrane was visualized by chemiluminescent substrate (EZ-ECL, Kibbutz Beit Haemek Israel). The immunoblotting for β-actin (Santa Cruz Biotechnology, Santa Cruz, CA) was used as a loading control.
Statistical analysis
Any significance in differences between two data sets was determined by the Student's t-test. P values < 0.05 were considered significant in all analyses.
Discussion
HSP70 protects gastric mucosal cells against intrinsic and extrinsic stimuli, and maintains the proper structure and function of the gastric mucosa [
14,
15], suggesting induction of HSP70 might be useful for medical treatment of diseases with mucosal damage. Tsukimi Y et al. found HSP70 may facilitate the healing of acetic acid-induced gastric ulcers in rats [
16]. Our previous study has demonstrated that up-regulation of HSP70 expression by Geranylgeranylacetone (GGA) interrupts the progression of atrophic gastritis in rats, as evidenced by the improvement of inflammation and glandular restoration in gastric mucosa [
12]. HSP70 could protect gastric mucosa from
H. pylori-associated gastrointestinal diseases [
17].
H. pylori infection destroyed gastric mucosa barrier function through inducing a significant reduction of HSP70 expression in gastric epithelial cells, which was supposed to disturb gastric adaptation and facilitate H pylori to avoid host immunity [
10]. We demonstrate here that suppression of HSP70 increased the sensitivity of gastric cells to
H. pylori infection with the inhibition of cellular growth and cell cycle progression, as well as induction of apoptosis.
H. pylori infection damages gastric mucosa by disturbing equilibrium between apoptosis and proliferation. HSPs could reverse these inferiorities in mucosal healing. Inhibition of endogenous HSP70 slowed cellular multiplication, and enhanced the effect of
H. pylori on cell viability. The anti-proliferation role of
H. pylori was more evident following the further depletion of HSP70 expression. HSP70 involving in cell growth could be a cell cycle event. Rohde M et al. reported that Hela cells transfected with siRNA against HSP70 revealed an arrest in G2/M phase of cell cycle [
18], which resulted in growth retardation with features of cell senescence. Our previous study have found that down-regulation of HSP70 induced S-phase arrest in AGS cells. Furthermore, we investigated the effect of HSP70 on the cell cycle of AGS cells infected with
H. pylori, and the results showed that depletion of HSP70 induced AGS cells accumulating in S-phase independent of
H. pylori infection. Our observation that HSP70-depletion induced S-phase arrest and p21 over-expression is in agreement with the previous report that transduction of the p21 gene resulted in S-phase arrest [
19,
20]. The p21 protein can inhibit DNA synthesis by interacting with PCNA [
21], and plays a regulatory role in S phase DNA replication and DNA damage repair [
22]. Growth arrest by p21 can promote cellular differentiation, and therefore prevents cell proliferation [
23].
HSP70 depletion could make AGS more susceptible to the cytotoxicity of
H. pylori by interference with apoptotic programs.
H. pylori is known to cause apoptosis of gastric epithelial cells by targeting mitochondria [
24,
25]. Mitochondria respond to multiple death stimuli. It has been demonstrated that pro-apoptotic Bcl-2 family proteins such as Bax could induce mitochondrial membrane permeabilization and cause the release of mitochondria-mediated apoptosis signaling molecules including cytochrome c and AIF [
26]. Cytochrome c triggers the caspase-dependent cascade [
27], but AIF executes cell death in the absence of caspase [
28‐
30].
H. pylori has been reported to trigger apoptosis in AGS cells via release of cytochrome c and AIF from mitochondria [
31]. Our study demonstrated that down-regulation of HSP70 induced the further release of cytochrome c and AIF in the AGS with
H. pylori infection, consistent with the hypothesis that HSP70 suppression could sensitize the gastric epithelial cells to the damage from
H. pylori.
Furthermore, we evaluated the role of extracellular HSP70 in
H. pylori-infected AGS cells, and demonstrated that extracellular HSP70 protein could partial compensate for the decreased intracellular HSP70 by reducing release of cytochrome c and AIF, which could block apoptosis in gastric cells with
H. pylori infection. Consistently, extracellular HSP70 could also modulate the proliferation of AGS cells by inhibiting expression of p21. The exogenous HSP70 might cross the cellular plasma membrane and reduce apoptosis with the decrease of toxicity protein aggregation [
32]. Exogenous HSP70 was suggested to be a trophic factor supporting cell survival [
33].
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
LWL acquired the majority of data (involving assay design, cell culture, cell transfection, cell cycle and protein analysis), wrote the manuscript and contributed to the design and concept of the study. CY & LGF performed cell culture, apoptosis and viability assay. LGF performed Western blot. SLM contributed to the concept of the study and cell culture. SJM conceived the studies, oversaw the experimental work and established all the collaborations. All authors read and approved the final manuscript.